Tagged with Turkey

Turkey * Dr Fabrizio Guidi has left his role as country chair & general manager Rx of Sanofi Turkey and is currently Sanofi’s general manager of diabetics and cardiovascular for Germany, Switzerland and Austria. From January 2019 Dr Guidi will become Sanofi’s general manager primary care GBU Germany, Switzerland and Austria and country…

Turkey Barış Özyurtlu, general manager of Berko Pharmaceuticals, one of the fastest growing companies in Turkey, provides insights into the company’s innovative vision and proprietary technologies, such as its spoon-shaped product presentation. The latter has already caught the attention of several partners in the US and Canada and should further propel…

Turkey Şekib Avdagiç, president of the Istanbul Chamber of Commerce and Istanbul Convention and Visitors Bureau (ICVB) provides an in-depth analysis of the ICVB’s services, the main trends shaping the city’s congress sector and the importance of the healthcare and life sciences industry to Istanbul’s corporate tourism.   Turkey is gifted…

Turkey Mahmut Oguzcan, country business leader of 3M Turkey, offers his expert insights into the Turkish medical devices market. He explains how Turkey’s Health Transformation Program (HTP) and private-public partnership (PPP) models have created opportunities and challenges for 3M and outlines its commitment to Turkey moving forward.   Turkey is home…

Turkey Ismail Yormaz, vice president & regional director south-east at Recordati, shares the management secrets that have helped him grow Recordati into one of the top pharma companies in Turkey. He also shares his advice on navigating the Turkish market and his visions for the future.   Running a pharmaceutical company…

Turkey Sule Mene, co-founder, president and CEO of Mene Health Group, shares with PharmaBoardroom the journey of her company starting as the first government-approved CRO of Turkey, its parallel growth alongside the increasingly prominent clinical trial environment of the country, evolution to becoming a value chain group of companies in clinical…

Turkey Tuğçe Koç reveals how Onko Koçsel was able to quickly grow from an in-licenser to a production-oriented pharmaceutical company with an international reach. She also offers her take on how the Turkish healthcare sector could encourage more companies to grow and how existing companies can combat economic fluctuations.   By…

Turkey Kazim Dinç, chairman of the board of SURDER and former Minister of Health of Turkey, offers his insights into the Turkish OTC and health products market, highlighting the challenges facing the industry and SURDER’s role in bringing about constructive reforms.   Before SURDER was established, there was a sizeable gap…

Turkey Despite the sharp decline in the Turkish lira’s value, the general mood among pharmaceutical executives in Turkey is positive. Rather than being discouraged, they are calling upon their resiliency and experience from former periods of economic fluctuation to push the Turkish healthcare and life sciences sector forward.   Turkey made…

Turkey Acibadem’s Mehmet Ali Aydınlar offers his insights into the Turkish healthcare sector, highlighting Turkey’s burgeoning healthcare tourism industry. He also describes Acıbadem’s focus of growth, globalization and fundamental values that have helped the hospital chain become a prominent trademark on a global scale.   In the following years, we will…

Turkey Murat Kavrar, country manager at Ekol Turkey, offers readers a look at Ekol’s innovative approach to the logistics sector, emphasizing his company’s R&D capacity and eco-friendly solutions that provide client companies with efficient, cost-saving logistics services.   We do logistics differently than our competition in Europe Could you introduce Ekol…

Turkey With the construction of state-of-the-art public and private hospitals, Turkey is poised to become a global leader in medical tourism.   Turkey has always been a popular tourist destination, given its unrivaled history and cultural appeal, and now, after years of large-scale investments by both the private and public sector,…